Business Standard

FDA authorises second booster of Pfizer/BioNTech, Moderna Covid shots

FDA authorises another booster dose of the Pfizer or Moderna Covid vaccine for people age 50 and up

Photo: Bloomberg

Photo: Bloomberg

The U.S. Food and Drug Administration on Tuesday authorized a second booster dose for people age 50 and older of the two most commonly used COVID-19 vaccines, citing data showing waning immunity and the risks posed by Omicron variants of the virus.

The agency said the new boosters - a fourth round of shots for most vaccine recipients - of the Pfizer Inc/BioNTech SE and Moderna Inc vaccines are to be administered at least four months after the previous dose. They are intended to offer more protection against severe disease and hospitalization.

The FDA also authorized the second booster dose of the

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 29 2022 | 8:23 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to